NT-814

Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market
Fierce Biotech
Tue, 08/11/20 - 01:30 pm
Bayer
KaNDy Therapeutics
M&A
Women's Health
menopause
hot flashes
NT-814
Women’s health firm KaNDy raises $32M for menopause study
Fierce Biotech
Wed, 08/29/18 - 10:22 am
KaNDy Therapeutics
clinical trials
menopause
NT-814